UPC NASDAQ
Universe Pharmaceuticals Inc.
1W: -5.3%
1M: -5.7%
3M: -25.0%
YTD: +8.2%
1Y: +2.3%
3Y: -99.2%
5Y: -100.0%
$4.50
+0.19 (+4.41%)
Weekly Expected Move ±12.3%
$3
$4
$4
$5
$6
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$5M
+46.9% ▲
Capital Expenditures
$347K
+4.4% ▲
5Y CAGR: +46.3%
Free Cash Flow
-$5M
+45.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$4M
-83.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $11M | -$8M | -$7M | -$9M | -$4M |
| Depreciation & Amort. | $447K | $534K | $509K | $486K | $517K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$13M | $7M | $6M | -$2M | -$2M |
| Other Non-Cash Items | -$468K | $6K | -$46K | $186K | $371K |
| Operating Cash Flow | -$2M | -$1M | $1M | -$10M | -$5M |
| — Investing Activities — | |||||
| Capital Expenditures | -$14M | -$94K | -$44K | -$246K | -$267K |
| Acquisitions (Net) | $27M | -$4M | $0 | $0 | $0 |
| Investment Purchases | -$15M | $0 | $0 | $0 | $0 |
| Investment Sales | $2M | $0 | $0 | $0 | $0 |
| Other Investing | -$27M | $523 | $0 | -$115K | -$75K |
| Investing Cash Flow | -$27M | -$4M | -$44K | -$361K | -$342K |
| — Financing Activities — | |||||
| Net Debt Issuance | $624K | $3M | -$1M | $9M | -$5M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$3M | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $27M | $3M | -$1M | $34M | $10M |
| Net Change in Cash | -$2M | -$2M | -$426K | $24M | $4M |
| Cash End of Period | $8M | $6M | $5M | $29M | $34M |
| Free Cash Flow | -$16M | -$1M | $1M | -$10M | -$5M |